Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.18 USD | +0.42% |
|
+11.84% | +19.87% |
09/07 | BioCryst Pharmaceuticals Says Orladeyo Approved in Peru | MT |
03/07 | Island Pharmaceuticals Acquiring Clinical-Stage Antiviral Molecule | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+19.87% | 147.56Cr | |
+20.63% | 13TCr | |
+24.16% | 2.8TCr | |
-20.17% | 2.05TCr | |
-16.06% | 1.71TCr | |
-18.07% | 1.61TCr | |
-47.70% | 1.5TCr | |
+11.92% | 1.48TCr | |
+58.32% | 1.44TCr | |
+149.98% | 1.24TCr |
- Stock Market
- Equities
- BCRX Stock
- News BioCryst Pharmaceuticals, Inc.
- Transcript : BioCryst Pharmaceuticals, Inc. Presents at 39th Annual JPMorgan Virtual Healthcare Conference, Jan-13-2021 08